Atlas Trials

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Clinical trial NCT04509635 · UNKNOWN

Trial details

NCT number
NCT04509635
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal CancerLiver MetastasesCetuximab
Start date
2020-09-01
Primary completion
2022-08-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.